Immupharma PLC - Notification of Change of AGM Venue
RNS: FOR IMMEDIATE RELEASE
("ImmuPharma" or the "Company")
Notification of Change of AGM Venue
ImmuPharma PLC (LSE:IMM), (Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company announces that the Company's Annual General Meeting (AGM) confirmed for Thursday,
The COVID-19 Guidance rules still apply, as set out in the announcement issued on
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 ("MAR").
For further information please contact:
Notes to Editors
We note the current issues surrounding COVID-19 (coronavirus) and the rapidly developing public health guidance in the UK at the time of writing. This includes the stringent requirements announced on
As it is no longer possible to hold the AGM in the way that the Board had planned, we cannot allow shareholders to attend in person. Any shareholders attempting to gain access to the AGM will be excluded from the meeting on grounds of public safety. In the light of the above, we strongly encourage you to consider ensuring your vote is counted by submission of the proxy by post as detailed in the Notice of Annual General Meeting.
This information is provided by RNS, the news service of the
Quick facts: ImmuPharma PLC
Market Cap: £25.62 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE